Advertisement
Tango Therapeutics, Inc. (TNGX)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Follow
At close: 04:00PM EST
After hours:
| Previous Close | 2.8300 |
| Open | 2.9000 |
| Bid | 2.9100 x 1300 |
| Ask | 2.9700 x 1300 |
| Day's Range | 2.7150 - 3.0250 |
| 52 Week Range | 2.7150 - 13.0050 |
| Volume | |
| Avg. Volume | 1,349,028 |
| Market Cap | 316.883M |
| Beta (5Y Monthly) | 0.88 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.1500 |
| Earnings Date | Nov 06, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12.50 |
Simply Wall St.Tango Therapeutics Third Quarter 2024 Earnings: Beats Expectations
Tango Therapeutics ( NASDAQ:TNGX ) Third Quarter 2024 Results Key Financial Results Revenue: US$11.6m (up 8.2% from 3Q...
Business WireTango Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights
BOSTON, November 06, 2024--Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, reported its financial results for the third quarter ended September 30, 2024, and provided business highlights.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.